Hycort Inj.
Generic Name: Hydrocortisone Sodium Succinate BP 100 mg/2 ml
Therapeutic Class: Glucocorticoids
Indication: Hycort is an injectable preparation of Hydrocortisone BP which is a synthetic corticosteroid.
Hydrocortisone is indicated for use in the following conditions:
Primary or secondary adrenocortical insufficiency
Acute adrenocortical insufficiency
Shock unresponsive to conventional therapy
Congenital adrenal hyperplasia
Hypercalcemia associated with cancer
Non-suppurative thyroiditis
Rheumatic Disorders
Dermatologic Diseases (Allergic States, Severe seborrheic dermatitis, Severe psoriasis, Pemphigus, Severe erythema multiforme)
Control of severe or incapacitating allergic conditions (Bronchial asthma, Contact dermatitis, Atopic dermatitis, Serum sickness, Seasonal or perennial allergic rhinitis, Drug hypersensitivity reactions, Urticarial transfusion reactions, Acute noninfectious laryngeal edema)
Ophthalmic Diseases (Herpes zoster ophthalmicus, Iritis, iridocyclitis, Chorioretinitis, Diffuse posterior uveitis and choroiditis, Optic neuritis)
Gastrointestinal Diseases
Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy
Loeffler's syndrome
Aspiration pneumonitis
Hematologic Disorders (Acquired, autoimmune hemolytic anemia, Idiopathic thrombocytopenic purpura in adults, Secondary thrombocytopenia, Erythroblastopenia)
Neoplastic Diseases (Leukemias and lymphomas in adults, Acute leukemia of childhood)
Edematous States
Acute exacerbations of multiple sclerosis
Dosage & Administration: Adult : by IM injection or slow IV injection or infusion, 100-500 mg, 3-4 times in 24 hours or as required.
Child: by slow IV Injection, up to 1 year: 25 mg, 1-5 years: 50 mg, 6-12 years: 100 mg.
Preparation: 1 ml X 1 Injection.